Literature DB >> 15678519

Is silence golden? A test of the incorporation of the effects of ill-health on income and leisure in health state valuations.

Pedram Sendi1, Werner B F Brouwer.   

Abstract

The objective of the present study was to evaluate whether people include the effects of ill-health on income and leisure in quality of life valuation when the measure is silent on both. A convenience sample of 20 health professionals had to rate a health status on a visual analogue scale (VAS) without being explicitly asked to consider the effects of ill-health on income and leisure. A majority of respondents (60%) does not consider income effects and 75% does consider the effects on leisure. Explicitly asking respondents to incorporate these effects lowers the valuation. Our results indicate that whatever separation between costs and effects is preferred, using quality of life measures which are silent on income and leisure, leads to either double-counting or ignoring real costs or effects. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15678519     DOI: 10.1002/hec.971

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  9 in total

1.  Does the EQ-5D reflect lost earnings?

Authors:  Carl Tilling; Marieke Krol; Aki Tsuchiya; John Brazier; Job van Exel; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2012-01       Impact factor: 4.981

2.  The friction-cost method : replacement for nothing and leisure for free?

Authors:  Werner B F Brouwer; Marc A Koopmanschap
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 3.  The relationship between productivity and health-related QOL: an exploration.

Authors:  Werner B F Brouwer; Willem-Jan Meerding; Leida M Lamers; Johan L Severens
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Productivity costs in health-state valuations : does explicit instruction matter?

Authors:  Marieke Krol; Werner Brouwer; Pedram Sendi
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 5.  Productivity costs in economic evaluations: past, present, future.

Authors:  Marieke Krol; Werner Brouwer; Frans Rutten
Journal:  Pharmacoeconomics       Date:  2013-07       Impact factor: 4.981

6.  How to estimate productivity costs in economic evaluations.

Authors:  Marieke Krol; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

Review 7.  Do productivity costs matter?: the impact of including productivity costs on the incremental costs of interventions targeted at depressive disorders.

Authors:  Marieke Krol; Jocé Papenburg; Marc Koopmanschap; Werner Brouwer
Journal:  Pharmacoeconomics       Date:  2011-07       Impact factor: 4.981

8.  Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.

Authors:  Pedram Sendi; Huldrych F Günthard; Mathew Simcock; Bruno Ledergerber; Jörg Schüpbach; Manuel Battegay
Journal:  PLoS One       Date:  2007-01-24       Impact factor: 3.240

9.  A cross-sectional survey of work and income loss consideration among patients with herpes zoster when completing a quality of life questionnaire.

Authors:  Kelly D Johnson; Susan K Brenneman; Chrisann Newransky; Seth Sheffler-Collins; Laura K Becker; Angela Belland; Camilo J Acosta
Journal:  BMC Health Serv Res       Date:  2018-08-25       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.